Clinical Trials for Hangzhou Adcoris Biopharmacy

Explore 2 clinical trials worldwide

Showing 1-2 of 2 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Hangzhou Adcoris Biopharmacy

Clinical Trials (2)

An Open-label, Multi-center, Dose-escalation and Cohort Expansion Phase I/IIa Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetic Profile and Efficacy of ACR246 in Patients With Advanced Solid Tumors

PHASE1Recruiting

77 participants

Started: Oct 29, 2024 · Completed: Jan 1, 2026

1 condition1 sponsor3 locations

Study of ZV0203 in Patients With HER2-Positive Advanced Solid Tumors

PHASE1Enrolling by invitation

36 participants

Started: Dec 17, 2021 · Completed: Jul 7, 2026

1 condition1 sponsor1 location